Skip to content

Clinical trials

Completed Phase 3 Hepatitis B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 3 Status: Completed Clear all

149 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20037
200413
20059
200629
20077
200811
20091
20107
201111
20126
20134
20146
20152
20164
20172
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed149

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline54
Sanofi Pasteur, a Sanofi Company23
Merck Sharp & Dohme LLC15
Dynavax Technologies Corporation5
Gilead Sciences5
Henogen5
VBI Vaccines Inc.4
Crucell Holland BV3
MCM Vaccines B.V.3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B149
Diphtheria53
Tetanus51
Haemophilus Infections43
Whooping Cough40
Poliomyelitis33
Hepatitis B, Chronic14
Hepatitis7
Hepatitis A7
Virus Diseases7

Trials

Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.

49 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.